Stock data
Endovia Health Sciences, Inc. (EDVA)
Endovia Health Sciences, Inc. (EDVA) reported revenue of US$0.07M and net income of -US$25.23M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$0.07M | US$0.02M | -US$14.19M | -US$25.23M | — |
| 2024 | US$0.80M | -US$0.12M | -US$9.90M | -US$23.76M | — |
| 2023 | US$18.85M | US$5.57M | -US$15.29M | -US$21.00M | — |
| 2022 | US$18.09M | US$5.92M | -US$21.39M | -US$21.69M | — |
| 2021 | US$11.32M | US$3.92M | -US$29.08M | -US$29.05M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$2.05M | — |
| 2026-03-31 | US$0.00M | -US$2.14M | — |
| 2025-12-31 | — | -US$3.21M | — |
| 2025-09-30 | — | -US$9.89M | — |
| 2025-06-30 | — | -US$8.49M | — |
| 2025-03-31 | US$0.07M | -US$3.65M | — |
| 2024-12-31 | -US$2.77M | -US$9.04M | — |
| 2024-09-30 | US$0.98M | -US$4.72M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.